Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

A Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE

ClinicalTrials.gov ID: NCT00914966

Public ClinicalTrials.gov record NCT00914966. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 6:51 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 4 Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE® (C1 Inhibitor [Human]) as Prophylactic Therapy in Subjects With Inadequately Controlled Hereditary Angioedema Attacks

Study identification

NCT ID
NCT00914966
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Shire
Industry
Enrollment
20 participants

Conditions and interventions

Interventions

  • C1 inhibitor (human) [C1 INH] Biological

Biological

Eligibility (public fields only)

Age range
6 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 30, 2009
Primary completion
May 23, 2012
Completion
May 23, 2012
Last update posted
Jun 22, 2021

2009 – 2012

United States locations

U.S. sites
11
U.S. states
9
U.S. cities
11
Facility City State ZIP Site status
Allergy, Asthma and Immunology Associates Scottsdale Arizona 85251
Family Allergy and Asthma Center Atlanta Georgia 30342
Institute for Asthma and Allergy Wheaton Maryland 20902
Winthrop University Hospital Mineola New York 11501
University of Cincinnati Medical Center Cincinnati Ohio 45267
Allergy and Asthma Research Group Eugene Oregon 97401
Baker Allergy, Asthma and Dermatology Research Center Lake Oswego Oregon 97035
East Tennessee Center for Clinical Research Knoxville Tennessee 37909
Not listed Bryan Texas 77802
AARA Research Center Dallas Texas 75231
Marycliff Allergy Specialist Spokane Washington 99204

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00914966, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 22, 2021 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00914966 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →